INSIGHTS ON CLINICAL TRIAL DESIGN
-
Factors Affecting Systemic Drug Exposure
The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.
-
Sustaining Participation In A 20-Year Alzheimer's Family Study
Learn how home-based visits can reduce burden, improve retention, and support long-term follow-up in complex clinical studies requiring years of continuous participation.
-
Overcoming Barriers To Clinical Trial Participation In Oncology
Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.
-
5 Common Gaps Between Patient Referral And Screening That Derail Trials
Up to 40% of clinical trial referrals drop off before screening due to financial, logistical, and administrative hurdles. Streamlining coordination and easing patient burden can boost enrollment.
-
Scaling Pharmacovigilance: Clinical Development To Commercialization10/1/2026
Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.
-
Biotech Landscape Continues To Shift9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
Unlocking The Potential of RWD In Clinical Trial Recruitment4/25/2025
Insights derived from real-world data can be used not only to identify potential patients for participation in clinical research, but also to inform the overall patient engagement and retention strategy of a clinical trial.
-
Lessons From The Front Lines: Navigating The Operational Challenges Of Next-Generation ADC Trials9/22/2026
See how smarter protocol design and real-time safety monitoring can ease patient burden and keep next-gen ADC oncology trials on track.
-
Where Study Simulation Fits In Clinical Trials4/21/2026
Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
-
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.
-
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.